Real-World Utilization of Lenvatinib and Pembrolizumab Combination Therapy for the Treatment of Endometrial Cancer in the USA

Q: How does OCRA curate its research paper database?

OCRA indexes peer-reviewed papers from PubMed and CrossRef, enriched with MeSH terms, author profiles, and citation metrics. Papers are categorized by cancer type, research method, and clinical relevance.

Q: Can I search papers by MeSH term or author?

Yes. Use the search bar to filter papers by MeSH term, author name, journal, keyword, or cancer type. Each paper includes linked MeSH terms and author profiles for further exploration.

Q: How current is the paper database?

The database is updated regularly through automated ingestion from PubMed and CrossRef. Most papers appear within days of their PubMed indexing date.

Inyoung Lee; Aimee Near; Vimalanand Prabhu

doi:10.2217/fon-2023-0058

Real-World Utilization of Lenvatinib and Pembrolizumab Combination Therapy for the Treatment of Endometrial Cancer in the USA

Inyoung Lee & Vimalanand Prabhu et al. · 2023-10-13

Real-World Utilization of Lenvatinib and Pembrolizumab Combination Therapy for the Treatment of Endometrial Cancer in the USA

Links

Journal

Institutions

Authors

Funding